Princy N Kumar
Affiliation: Georgetown University
- A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicityP N Kumar
Georgetown University Medical Center, Washington, DC 20007, USA
HIV Med 7:85-98. 2006....
- A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)Princy N Kumar
Georgetown University Medical Center, Washington, DC, USA
AIDS Res Ther 6:3. 2009..Both regimens offer benefits in select therapy-naÃ¯ve subjects. TRIAL REGISTRATION: [Clinical Trials Identifier, NCT00082394]...
- Lamivudine for the treatment of HIVPrincy N Kumar
Division of Infectious Diseases, Georgetown University, Washington, DC 20007, USA
Expert Opin Drug Metab Toxicol 6:105-14. 2010..It also has one of the best tolerability and long-term safety profiles among all antiretroviral agents and continues to be preferred as part of initial or subsequent combination therapy in HIV-infected patients...
- Contemporary role of nevirapine in HIV treatmentLaura O Coster
Georgetown University Medical Center, Division of Infectious Diseases, Washington, DC 20007, USA
AIDS Rev 14:132-44. 2012..This review focuses on current information regarding the role of nevirapine in HAART and defines patient groups whose clinical profiles may warrant consideration of nevirapine...
- Pharmacologic issues of antiretroviral agents and immunosuppressive regimens in HIV-infected solid organ transplant recipientsJennifer Primeggia
Georgetown University Medical Center, Division of Infectious Diseases, Department of Medicine, Washington, DC 20007 2113, USA
Infect Dis Clin North Am 27:473-86. 2013..As more antiretroviral regimens are cautiously initiated in the posttransplant period, further research is needed to identify drug-drug interactions to minimize toxicities and improve long-term survival and graft function...
- Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapyGayle P Balba
Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA
Am J Med 119:448.e21-5. 2006..From October 2001 to October 2002, we have observed a surprisingly high incidence of ocular syphilis in human immunodeficiency virus-positive (HIV+) patients receiving highly active antiretroviral therapy at our clinic...